For comments, suggestions
Created with Raphaël 2.1.0 17.06.2016 Filing date 17.01.2018 Validation fee payment 30.06.2018 (A1) Patent application published 06.05.2021 AGEPI application filing date 31.07.2021 (T2) Translation of the validated European patent 26.04.2025 17.06.2025 Valid until 18.06.2026 Renewal fee to be paid until 17.06.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16729601
(220)Filing date of the EPO application2016.06.17
(80)EPO patent specification publication (B)EPB nr. 13/2021, 2021.03.31
(110)EPO patent number3310345
(11)Number of the documentMD 3310345 T2
(21)Number of the applicatione 2018 0402
(71)Name(s) of applicant(s), code of the countryESTETRA SPRL, BE;
(72)Name(s) of inventor(s), code of the countryJASPART Séverine Francine Isabelle, BE;
PLATTEEUW Johannes Jan, NL;
VAN DEN HEUVEL Denny Johan Marijn, NL;
(73)Name(s) of owner(s), code of the countryESTETRA SPRL, BE;
(54)Title of the inventionOrodispersible tablet containing estetrol
(13)Kind-of-document code T2
(51)International Patent Classification A61K 9/20 (2006.01.01); A61K 31/565 (2006.01.01); A61P 5/30 (2006.01.01); A61P 15/18 (2006.01.01)
(19)CountryBE
(41)Date of publication of the application2018.06.30
(49)Date of publication of the translation of the validated European patent specification2021.07.31
(30)Priority15172751, 2015.06.18, EP
(74)Patent attorney(Procedură) ŞCERBANIUC Sergiu, Z Tower Business Center, Str. Calea Ieșilor nr. 8, et. 3, of. 6, MD-2069, Chișinău,Republica Moldova
(86)International applicationPCT/EP2016/064071, 2016.06.17
(87)International publicationWO 2016/203009, 2016.12.22
Up
/Inventions/details/3310345